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Abstract
Long-term functional stability of isolated membrane proteins is crucial for many in vitro appli-
cations used to elucidate molecular mechanisms, and used for drug screening platforms in
modern pharmaceutical industry. Compared to soluble proteins, the understanding at the
molecular level of membrane proteins remains a challenge. This is partly due to the difficulty
to isolate and simultaneously maintain their structural and functional stability, because of
their hydrophobic nature. Here we show, how scintillation proximity assay can be used to
analyze time-resolved high-affinity ligand binding to membrane proteins solubilized in vari-
ous environments. The assay was used to establish conditions that preserved the biological
function of isolated human kappa opioid receptor. In detergent solution the receptor lost
high-affinity ligand binding to a radiolabelled ligand within minutes at room temperature.
After reconstitution in Nanodiscs made of phospholipid bilayer the half-life of high-affinity
ligand binding to the majority of receptors increased 70-fold compared to detergent solubi-
lized receptors—a level of stability that is appropriate for further downstream applications.
Time-resolved scintillation proximity assay has the potential to screen numerous conditions
in parallel to obtain high levels of stable and active membrane proteins, which are intrinsi-
cally unstable in detergent solution, and with minimum material consumption.
Introduction
Membrane proteins (MPs) are key components in cell communication. They act as transport-
ers of molecules across the plasma membrane or they function as enzymes or receptors that
transmit outside stimuli to intracellular responses. Because of their predominant role in cellular
signaling and physiological processes, altered function of MPs are involved in many severe dis-
eases. Consequently MPs are targets for more than 60% of approved drugs on the market [1].
PLOSONE | DOI:10.1371/journal.pone.0150658 April 1, 2016 1 / 18
OPEN ACCESS
Citation: Hansen RW, Wang X, Golab A, Bornert O,
Oswald C, Wagner R, et al. (2016) Functional
Stability of the Human Kappa Opioid Receptor
Reconstituted in Nanodiscs Revealed by a Time-
Resolved Scintillation Proximity Assay. PLoS ONE 11
(4): e0150658. doi:10.1371/journal.pone.0150658
Editor: Debra Kendall, University of Connecticut,
UNITED STATES
Received: July 29, 2015
Accepted: February 16, 2016
Published: April 1, 2016
Copyright: © 2016 Hansen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: UNIK Synthetic Biology founded by the
Danish Ministry of Science and the Lundbeck
Foundation Center for Biomembranes in
Nanomedicine supported this work.
Competing Interests: The authors have declared
that no competing interests exist.
Abbreviations: CHS, Cholesteryl hemisuccinate;
DDM, n-Dodecyl-β-D-maltoside; DPN, Diprenorpine;
Dyn A, Dynorphin A; GPCRs, G protein coupled
In combination with cell-based screening approaches, an important stage in early drug dis-
covery processes, and rational drug design is often experimental verification and validation on
proteins isolated from the complex cellular environment [2–4]. During this process, a combi-
nation of structural studies, together with biochemical, and biophysical studies is essential for
lead identification and optimization to develop potential new drug candidates [5]. For this pur-
pose, a wide range of complementary methods and techniques are used, such as biochemical
analyses to elucidate the pharmacology of identified new hits [6,7], and biophysical methods,
including fluorescence spectroscopy [8], solid state nuclear magnetic resonance (NMR)
[4,9,10], and surface plasmon resonance (SPR) [11,12] to determine the protein structure and
relate it to thermodynamic and kinetic binding parameters of ligand-protein interactions.
For the above-mentioned methods, there are several requirements regarding the sample
quality of the isolated proteins. In the case of MPs, this is a tremendous challenge because of
their hydrophobic core. MPs have to be produced at high quantities, extracted from cell mem-
branes, and are often purified in detergent micelles. Although mild detergents are used to han-
dle MPs in solution, detergents often have a dramatic effect on the biological function,
especially if the proteins are exposed to detergents for extended periods [13,14]. Despite the
development of new strategies and techniques to stabilize MPs in the last two decades, it is still
an extensive challenge to isolate functional and stable MPs, especially integral MPs such as G
protein coupled receptors (GPCRs) [15–18].
One successful approach to stabilize the biological activity of MPs, is to generate thermosta-
bilized proteins suitable for e.g. small compound screening by SPR and NMR [19]. This
approach has been successfully adapted to several GPCRs [20,21]. However, this method is
often laborious due to the protracted process of generating thermostabilized GPCRs that still
have their original biological properties retained after genetic modifications. A different
approach is to stabilize native GPCRs in a lipid environment, such as lipoprotein particles
known as Nanodiscs or the similar high-density lipoprotein (rHDL) particles. The lipoprotein
particles consist of a lipid bilayer encircled by two amphipathic membrane scaffold proteins
(MSPs). The surrounding MSPs maintain the lipid bilayer as well-defined nanometer-sized
particles. When lipids, MSPs and target MPs are mixed in detergent solution, MPs are reconsti-
tuted in Nanodiscs by self-assembly upon detergent removal. Thus the lipoprotein particles
can be handled as soluble proteins, while the MPs can reside in a physiologically relevant
medium. Nanodiscs and rHDL have proven to be a powerful method to stabilize and handle
MPs in aqueous solutions. Numerous MPs, with a broad range of biological functions, have
been reconstituted in the lipoprotein particles [15]. Furthermore, the above-mentioned bio-
physical methods have been shown to be compatible with MPs/Nanodisc complexes [9,11,22–
24]. However, there is insufficient evidence of the functional stability of MPs in Nanodiscs, for
periods compatible with biophysical and pharmacological investigations.
In order to quantify the functional stability of a GPCR reconstituted in Nanodiscs, we have
extended a well-established radioactive assay, scintillation proximity assay (SPA), to measure
time-dependent high-affinity ligand binding to a GPCR. SPA is a radioligand surface sensitive
technique, based on beads filled with scintillant. This allows specific detection of receptor
bound ligands without prior separation from free ligand. Furthermore, the technique reduces
material consumption and allows higher throughput, compared to conventional filter-based
methods [6]. SPA has been utilized for a broad class of drug targets, and the assay can be used
for MPs in various environments, including membrane fractions, detergent solution [6,25,26]
or reconstituted in Nanodiscs [27,28].
To evaluate SPA as a time-resolved stability assay, we measured high-affinity ligand binding
to a representative GPCR, the kappa opioid receptor (KOR), either in detergent solution or
reconstituted in Nanodiscs. KOR is a class A GPCR widely distributed in the nervous system,
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where it is involved in the regulation of behavioral processes as perception, reward and mood
[29]. The receptor responds to the endogenous peptide ligand dynorphin A, which regulates
various functional pathways in the brain. As a consequence, KOR is believed to have a crucial
role in neuropsychiatric disorders such as depression, stress and addiction and is hence a phar-
maceutical important drug target [30]. The crystal structure of KOR has been solved recently,
nevertheless biochemical and biophysical investigations on the isolated receptor are still limited
due to the poor stability of the protein in detergent [31].
Using time-resolved SPA, we show that the ligand binding activity of KOR decreases rapidly
when KOR is in detergent micelles. When KOR is reconstituted into Nanodiscs the receptor
pharmacology is restored and most importantly the ligand binding activity is stable over several
hours at room temperature. We demonstrate that SPA can be used as a quick and easy
approach using minute amounts of receptor, to quantify the stability of GPCRs required for
many in vitro applications. Time-resolved SPA can easily be implemented in routine and auto-
mated drug discovery procedures to screen conditions for long-term stability of isolated MPs
in general.
Materials and Methods
Expression of KOR in Pichia pastoris and isolation of membrane
Human kappa opioid receptor (KOR) was expressed in Pichia pastoris (P. pastoris) as previ-
ously described [32]. The KOR sequence contained a N-terminal Flag-tag and a decahistidine-
tag followed by a tobacco etch virus (TEV) protease site. After the KOR reading frame the C-
terminus comprised a second TEV site followed by the biotinylation domain of the transcar-
boxylase from Propionibacterium shermanii. Yeast cells expressing KOR, were broken with
glass beads (Sigma beads, acid washed, G8772-1kg, 0,5 mm in diameter) using a BeadBeater
(Biospec Products). All procedures were performed at 4°C or on ice. Cells were suspended in
lysis buffer (50 mM Tris-HCl pH 7.4, 0.5 M NaCl, 0.1 mM TCEP, 1 mM PMSF, 5% glycerol, 5
mM EDTA, 1 tablet of Complete protease inhibitor cocktail). Membranes were separated from
cell debris by low-speed centrifugation of 3000 x g for 5 min at 4°C. The retained supernatant
was further centrifuged at 120000 x g for 30 min at 4°C (Sorvall discovery M120, Hitachi) to
collect the membranes. The membranes were re-suspended in membrane buffer (50 mM Tris-
HCl pH 7.4, 0.5 M NaCl, 0.1 mM TCEP, 1 mM PMSF, 5% glycerol, 20 μM naltrexone
(Sigma)). Protein concentration was quantified by bicinchoninic acid (BCA) assay (Pierce)
using bovine serum albumin as standard and following the manufacture’s instructions. Pre-
pared membranes were stored at -80°C.
Radioligand filter binding assay
Specific ligand binding to KOR in P. pastorismembranes was measured by radioligand filter
binding assay. Isolated P. pastorismembranes were diluted in binding buffer (50 mM Tris-HCl
pH 7.4, 0.5 M NaCl, 1mg/ml BSA) and mixed in triplicates with radioligand [3H]-diprenorpine
(DPN, 42.3 Ci/mmol, Perkin Elmer) in concentrations varying from 0.08 to 10 nM in a 96 well
plate (MultiScreen HTS-FC 1.2/0.65 μm glass fiber filter), which was pre-wetted in washing
buffer (50 mM Tris-HCl buffer, pH 7.4). Non-specific binding was measured in parallel by
including 50 μM naloxone. For each binding experiment, membranes corresponding to
3–5 μg/well were used keeping the ratio of bound radioligand<10% of the total added radioli-
gand. The assay mixture was incubated for 2 h at room temperature. To separate bound from
free ligands, the plate was rapidly filtrated and washed four times with 100 μl ice-cold washing
buffer. Scintillation liquid (Ultima Gold XR, Perkin Elmer) was added to the wells and the
assay was counted by a liquid scintillation counter (Wallac Microbeta TriLux 1450). Specific
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binding was calculated and KD was measured from saturation curves fitted to a one-site bind-
ing model using Igor Pro 6.1.
Extraction of membrane proteins in detergent
All steps were done at 4°C or on ice. Isolated membranes were diluted to 5 mg/ml with 50 mM
Tris-HCl, pH 7.4, 500 mMNaCl, 5% glycerol, 1 mM PMSF, 0.1 mM TCEP, 10 mM imidazole.
When solubilized MPs were used for purification, 20 μMNTX was included in the buffer.
Detergent n-Dodecyl-β-D-maltoside (DDM) mixed with cholesteryl hemisuccinate tris salt
(CHS) was added to a final concentration of 1%/0.2% DDM/CHS (w/v) and incubated for 15
min at 4°C. The suspension was centrifuged for 20 min at 120000 x g to pellet non-solubilized
material. Solubilized MPs were used directly for SPA assay or purification.
Purification and reconstitution in Nanodiscs
Solubilized MPs were purified by immobilized metal ion affinity chromatography (IMAC) on a
HisTrap HP column (GE Healthcare, 1 ml) connected to a manual pump at 4°C. The column
was equilibrated in purification buffer (50 mM Tris-HCl, 500 mMNaCl, 5% glycerol, 1 mM
PMSF, 0.1 mM TCEP, 20 μMNTX with 10 mM imidazole, 0.1%/0.02% DDM/CHS (w/v), pH
7.4). Solubilized proteins were loaded on the column and washed in purification buffer until
baseline was reached (UV absorbance 280 nm). Proteins were eluted by elution buffer (50 mM
Tris-HCl, 500 mMNaCl, 5% glycerol, 1 mM PMSF, 0.1 mM TCEP, 500 mM imidazole, 20 μM
NTX, 0.1%/0.02% DDM/CHS (w/v), pH 7.4) and eluted fractions containing protein were
pooled. The membrane scaffold protein MSP1E3D1 construct was provided by the group of S.
Sligar. Expression and purification was carried out as previously published [33]. POPC (1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG (1-palmitoyl-2-oleoyl-sn-glycero-
3-phospho-(1'-rac-glycerol)) lipids (Avanti Polar lipids) were prepared by dissolving lipids (3:2
molar ratio POPC:POPG) in chloroform and dried with a gentle stream of nitrogen on the
edge of a glass tube. MSP1E3D1 and POPC:POPG were mixed in 20 mM Tris-HCl pH 7.4, 100
mMNaCl, 50 mM sodium cholate (final concentration) buffer in the ratio 1:110 MSP:lipids
(molar ratio). IMAC purified proteins were mixed immediately after elution from the HisTrap
HP column with lipids (POPC:POPG 3:2, molar ratio) and MSP1E3D1 in a ratio of 1:10, pro-
tein:MSP (molar ratio) and incubated 15 min on ice. Self-assembly of Nanodiscs was initiated
by detergent removal with the addition of BioBeads SM-2 (Biorad) 1 mg/ml. Samples incu-
bated with biobeads overnight at 4°C and were then removed by filtration (0.22 μm). KOR/
Nanodisc complexes were further purified utilizing an anti-Flag M2 Affinity Gel (Sigma). The
column was prepared according to the manufactures recommendations. 1 ml resin was equili-
brated in standard buffer (20 mM Tris-HCl pH 7.4, 100 mMNaCl), sample was mixed with
the resin and incubated for 2 h at 4°C. After incubation, the column was washed in standard
buffer until UV absorbance 280 nm reached a value below 0.01 AU. Anti-Flag peptide was
diluted in standard buffer to 0.15 mg/ml, mixed with the resin and the mixture was incubated
at 4°C for 30 min. Subsequently, KOR/Nanodisc complexes were eluted from the column by
washing the column in standard buffer. Fractions containing protein (UV absorbance 280 nm)
were collected and concentrated (30 kDa MWCO, MilliPore). Finally, the concentrated protein
was injected onto a Superdex 200 10/300 GL (GE Healthcare) pre-equilibrated with standard
buffer on an ÄKTA FPLC system at a flow rate of 0.5 ml/min. To estimate the Stokes radius of
the eluted proteins, the Superdex 200 column was calibrated with standard proteins from gel
filtration calibration kits LMW and HMW (GE Healthcare). Eluted proteins, corresponding to
KOR/Nanodisc complexes, were collected and concentrated (30000 Da MWCO, MilliPore) to
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a protein concentration corresponding to approximately 0.2 mg/ml. Samples were either stored
at 4°C or frozen and stored at– 80°C.
SDS-PAGE andWestern blotting
KOR/Nanodisc samples were diluted in NuPage LDS buffer including 0.3% SDS and separated
on a 10% Bis-Tris gel (NuPAGE, Invitrogen) in MES buffer at 200 V. The gel was either stained
in Coomassie blue (Sigma) or transferred to a methanol pre-treated PVDF membrane (Invitro-
gen) for 1 hour at 30 V in transfer buffer (10 mM Tris-HCl, 150 mMNaCl, 0,05% Tween-20,
pH 7.5). The PVDF membrane was washed in ultra pure water and blocked in blocking buffer
(10 mM Tris-HCl, 150 mMNaCl, 0.05% Tween-20, 3% milk powder BioRad) for 1 hour at
room temperature. KOR was detected through the C-terminal biotin-tag by incubation with
streptavidin alkaline phosphatase (Sigma), diluted (1:10000) in blocking buffer, and incubated
for 1 hour with the PVDF membrane. The blot was washed 3 times in washing buffer (10 mM
Tris-HCl pH 7.5, 150 mMNaCl, 0.05% Tween-20) and finally, the colorimetric reaction was
developed for 5–30 min with alkaline phosphatase substrate, NBT/BCIP (Thermo Scientific).
The intensity of bands of the Coomassie blue stained gel was analyzed by ImageJ Gel Analyzer.
MALDI mass spectrometry
From the Coomassie blue stained gel the band corresponding to KOR was cut and analyzed on
a Bruker Autoflex Speed MALDI TOF/TOF instrument. Before loading, protein samples were
reduced and alkylated with iodoacetamide and subsequently digested with trypsin. The result-
ing peptides were concentrated and eluted onto an anchorchip. The peptide mixture was ana-
lyzed in positive reflector mode. The MS and MS/MS spectra were combined and used for
database searching using the Mascot software.
SPA assay
All procedures were performed on ice or at 4°C until assay counting was initiated at room tem-
perature (23°C). Time-resolved stability assay with detergent-extracted MPs was carried out
directly after solubilization in binding buffer I (20 mM Tris-HCl, pH 7.4, 500 mMNaCl, 5%
glycerol, 1 mM PMSF, 0.1 mM TCEP, 0.4% BSA). Solubilized proteins were diluted in the
assay resulting in a final concentration of 0.1% DDM in the assay buffer. Stability assays per-
formed with KOR reconstituted in Nanodiscs were done in binding buffer II (20 mM Tris-HCl
pH 7.4, 100 mMNaCl pH 7.4, 0.4% BSA). KOR/Nanodisc samples were added at quantities
corresponding to approximately 30 fmol/well. Samples were mixed with 0.5 mg/well yttrium
silicate (YSi) streptavidin coated SPA beads (Perkin Elmer) in binding buffer and a final con-
centrations of 10 nM [3H]-DPN (42.3 Ci/mmol, Perkin Elmer) in a total volume of 200 μl. In
parallel, the non-specific binding was measured including 50 μM naloxone in the assay. All
measurements were performed in triplicates in a white-wall clear-bottom 96-well plate (Wal-
lac). The assay was gently shaken on a vibrating platform at 4°C for 1.5 hours to equilibrate
ligand binding and immobilization of receptors on the SPA beads. After incubation the assay
was counted with a liquid scintillation counter (Wallac Microbeta TriLux 1450, SPA cpm
mode) repeatedly with 17 min between measurements at room temperature. As a control, the
same assay conditions as described above were performed at RT and bound and free radioli-
gands were separated at specific time points on Sephadex G-50 gravity-flow columns (GE
Healthcare) equilibrated in binding buffer. After applying 50 μl of samples, columns were cen-
trifuged for 2 min at 1000 x g. Separated samples were mixed with scintillation liquid and incu-
bated for 1 hour at RT, before counting on a liquid scintillation counter. As data analysis,
specific binding was normalized to the initial binding at time zero, corresponding to initiation
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of assay counting at RT. The half-life of high-affinity ligand binding was calculated from fitting
to single or double exponential decay functions in Igor Pro 6.1.
In SPA saturation binding experiments, KOR/Nanodisc (30 fmol) complexes were mixed as
above but with various concentrations of [3H]-DPN (0.08–10 nM). In parallel non-specific
binding was measured in the presence of 50 μM naloxone. During purification and reconstitu-
tion active KOR was up-concentrated, as compared to the detergent solubilized receptor sam-
ple. Therefore, saturation and inhibition binding assays were performed with reduced SPA
beads/well; 0.25 mg/well of streptavidin-coated SPA YSI beads. Competition binding assays
were performed with similar conditions, but with various concentrations of either naloxone or
dynorphin A (1–17) (Anaspec) corresponding to final ligand concentrations of 10−11 to 10−4
M. To measure KD and IC50, data corresponding to specific binding, were fitted to a one-site
binding model using Igor Pro 6.1. Ki was measured from the IC50 value.
G-protein binding assay
Heterotrimeric Gi proteins (Gαi bovine, His6-rat Gβ1 and bovine Gγ2) were expressed in Sf9
insect cells and co-purified as heterotrimeric proteins by IMAC chromatography as described
in [34]. GTPγS binding experiments were carried out using the fluorescent BODIPY FL GTPγS
(Life Technologies) analog as described in [35]. Binding reactions were done in assay buffer 50
mM Tris-HCl, pH 7.4, 150 mMNaCl, 100 μM EDTA, 3 mMMgCl2. Gi proteins were first
diluted in assay buffer including 0.012% DDM and were further diluted in the assay having a
final concentration of 0.0012% DDM. KOR/Nanodisc complexes, Gi proteins and BODIPY FL
GTPγS were mixed having final concentrations of 10 nM active receptors, 100 nM Gi proteins
and 100 nM BODIPY FL GTPγS. The assay was incubated for 25 min at 20°C and fluorescence
emission was recorded at 509 nm (± 3 nm) with an excitation at 490 nm (±2 nm) on a Fluoro-
Max-4 Spectrometer. In presence of ligand, KOR/Nanodisc complexes were pre-incubated
with 1 μM dynorphin A (1–17) (Anaspec). As a control, the same assay was performed with
similar concentration of empty Nanodiscs. All data were corrected for BODIPY FL GTPγS
background.
Results
KOR was expressed in P. pastoris with a N-terminal Flag- and decahistdine-tag, and a C-termi-
nal biotin-tag as earlier described [32]. Receptors were extracted from isolated membrane frac-
tions in a mixture of n-Dodecyl-β-D-maltoside (DDM) and the cholesterol-like molecule
cholesteryl hemisuccinate (CHS) to improve the stability of KOR (1%/0.2% DDM/CHS (w/v))
[36]. The time dependent stability of high-affinity ligand binding to KOR in detergent micelles
was assayed by time-resolved SPA.
Ligand binding stability to detergent solubilized KORmeasured by time-
resolved scintillation proximity assay
SPA is a homogeneous assay technology, where the target protein is immobilized on beads
filled with a scintillation matrix. Only radioligand within close proximity to the SPA beads can
efficiently transfer energy from the radioisotope decay to the scintillator inside the beads,
which generates a light signal (Fig 1) [6,37,38]. Thereby, it is not required to include a filtration
step to separate bound from free ligand in a receptor-binding assay. Monitoring the same assay
over longer period of time, allows the detection of changes in ligand binding, such as reduction
in ligand binding to the receptor, due to loss of receptor stability (Fig 1A).
Detergent solubilized KOR was immobilized on streptavidin coated SPA beads utilizing the
C-terminal biotin-tag. The samples were equilibrated at 4°C, with radiolabeled antagonist,
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[3H]-DPN, at a concentration corresponding to saturating conditions for high-affinity binding
(10 nM [3H]-DPN 10 x KD). The time-dependent ligand binding to KOR was measured by
counting the assay repeatedly for several hours at room temperature (23°C). As seen on Fig 1B,
the specific binding of [3H]-DPN to KOR decreased rapidly and with a complete loss of ligand
binding activity within 100 minutes at room temperature (Fig 1B).
To confirm that the observed decay was a result of KOR loosing its ligand binding capacity,
we used a conventional ligand binding assay based on desalting gravity flow columns, to mea-
sure specific ligand binding to detergent solubilized receptors incubated at room temperature
at various time points [39,40]. Using the same assay conditions, samples were applied to the
gravity flow columns to separate bound from free ligand. The measured decrease in ligand
binding signal detected by the two different assay techniques were similar. Their fits by an
exponential decay function [41] (Fig 1B) provided similar half-life of high-affinity ligand bind-
ing to receptors: 15.3 ± 0.5 minutes and 18.5 ± 2.3 minutes measured by SPA and by gravity
flow columns, respectively. However, the higher number of data points obtained with the SPA
method allowed a more detailed measurement of the ligand binding activity decay and better
fit of the data, than the measurements done with desalting gravity flow columns.
Comparison of the data from the two different assay methods, demonstrated that the
observed decay of ligand binding is in fact due to receptors losing their high-affinity for the
ligand and not as consequence of immobilization on the SPA beads. Furthermore, the assay
stability was confirmed by the continuous signal from [3H]-biotin immobilized on the strepta-
vidin coated SPA beads.
Fig 1. Principle of time-resolved Scintillation Proximity Assay (SPA) to quantify stability of high-affinity radio-ligand binding to GPCRs. A)
Receptors are immobilized on the SPA beads. When radioligands bind to immobilized receptors, energy from the radioisotope decay is efficiently transferred
to the scintillator contained in the beads, thus generating a detectable light signal. If the buffer, including detergent, causes the loss of receptor affinity to
radiolabeled ligand, the signal will start to decrease irreversibly. The decay of high-affinity ligand binding to receptors can be measured when the same assay
is counted repeatedly over time. B) Comparison of desalting gravity flow separation columns (blue circles) and SPA (black circles) to measure decrease in
binding of [3H]-DPN to KOR over time at room temperature. KOR was solubilized in 1%/0.2% DDM/CHS (w/v) and diluted in the assay to 0.1%/0.02% DDM/
CHS (w/v). Specific binding was normalized to initial binding. As control of assay stability, the signal of bead-immobilized [3H]-biotin was measured in parallel
(red circles). Error bars are standard error of the mean from four (gravity flow columns) or three (SPA) independent experiments each done in triplicates. To
quantify the stability of ligand binding, data was fitted to an exponential decay function (solid and dashed lines).
doi:10.1371/journal.pone.0150658.g001
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Compared to other separation techniques, such as desalting gravity flow columns, many
experimental conditions could be handled in parallel, which increases the throughput and
allows for rapid optimization of conditions that stabilize the function of MPs in detergent. In
addition, a large number of data points are obtained in one assay and the consumption of
materials is reduced considerably, since the same assay plate is counted repeatedly. This makes
SPA an efficient method to screen for optimal solubilization conditions that stabilize the bio-
logical function of MPs.
We tested several detergents and solubilization conditions, using SPA as a screening
method. Only minor changes in the measured stability of ligand binding to KOR were observed
(S1 Fig). In all cases, detergent had a dramatic effect on the ligand binding ability of KOR. The
rapid degradation of the high-affinity ligand binding to KOR, made it essential to stabilize the
receptor in an environment different from detergent micelles, to maintain a fully functional
receptor over time that was suitable for downstream analysis.
Purification and reconstitution in Nanodiscs
To stabilize KOR in a functional state for extended periods of time, we aimed at reconstituting
the receptor in Nanodiscs as a defined lipid bilayer. Two main approaches have been used to
reconstitute MPs in Nanodiscs. One is to purify MPs using multiple chromatography steps
prior to reconstitution in Nanodiscs [39,42]. It requires that MPs remain functional during
purification or that their function is restored after reconstitution. Another strategy, used for
very unstable MPs, is to capture all extracted MPs in Nanodiscs right after solubilization and
purify the target protein after stabilization in Nanodiscs [10,43–45]. Using this later approach
minimizes the time MPs are in contact with detergent micelles. However, compared to purified
proteins, a larger amount of material is reconstituted, thus the method may require vast
amounts of lipids and MSP. We chose an intermediate approach, where solubilized KOR was
quickly purified by IMAC, followed by reconstitution into Nanodiscs and several subsequent
purification steps.
The first IMAC purification removed a large part of other solubilized MPs and reduced
detergent concentration from 1% to 0.1% DDM, which facilitated detergent removal and the
initiation of Nanodiscs self-assembly. To favor the assembly of a single receptor per Nanodisc,
reconstitution was prepared with a 10-fold molar excess of MSP1E3D1 to IMAC purified
KOR, and with a lipid composition consisting of POPC and POPG (3:2). The 10-fold ratio has
shown to be optimal for the assembly of one GPCR per Nanodisc [46,47], and this lipid com-
position has been found to be optimal for other GPCRs [39,48,49]. After reconstitution and
detergent removal, KOR was further purified by its N-terminal FLAG-tag using affinity chro-
matography (anti-FLAGM2). In addition to increase sample purity, the anti-FLAG purifica-
tion step removed excess of empty Nanodiscs. As a last separation step, KOR/Nanodisc
complexes were separated by size exclusion chromatography (SEC) (Fig 2A).
The final SEC profile revealed two peaks (Fig 2A). Specific binding of [3H]-DPN to KOR in
eluted SEC fractions indicated that the second peak corresponded to active KOR reconstituted
in Nanodiscs (Fig 2A). The Stokes diameter of Nanodiscs particles containing KOR was calcu-
lated to be close to 14.1 nm, which was slightly larger than the measured Stokes diameter of
empty Nanodiscs, evaluated at 11.9 nm. Both values are in accordance with reported literature
values of MSP1D1E3 Nanodiscs [15,45]. When fractions from the second peak were analyzed
with SDS-PAGE (Fig 2B, S2 Fig), bands corresponding to both KOR (66 kDa) and the
MSP1E3D1 protein around the Nanodiscs (32.6 kDa) were detected. In addition, a faint band
just below 50 kDa was visible on the Western blot. This band may corresponds either to par-
tially degraded receptors or non-glycosylated receptors as previously reported [50]. The
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presence of KOR was further verified both by western blotting (Fig 2B, S2 Fig) and MALDI
mass spectrometry (S1 Table). The purity of isolated KOR/nanodics complexes was high when
the Coomassie-stained gel was assessed and furthermore the intensity of the band correspond-
ing to KOR was about half of the intensity of the band derived from the MSP protein (Fig 2B).
This indicates the expected stoichiometry of one receptor for two MSP proteins, but it cannot
be excluded that more than one receptor was reconstituted per Nanodisc. Taken together, the
above characterization indicated that KOR was homogeneously isolated and reconstituted in
Nanodiscs.
Long-term stability of KOR in Nanodiscs
To perform functional studies of GPCRs in general, it is essential to stabilize and maintain the
biological activity for a relatively long period of time. We used time-resolved SPA to investigate
the evolution of high-affinity ligand binding to KOR reconstituted in Nanodiscs over time.
With only 30 fmol active receptors reconstituted in Nanodiscs, we were able to confirm the
stability of high-affinity ligand binding over 12 hours at room temperature (Fig 3). KOR recon-
stituted in Nanodiscs showed a highly improved ability to bind [3H]-DPN with high-affinity
for a prolong period of time compared to KOR in 0.1%/0.02% DDM/CHS. After counting for
100 minutes, where the ligand binding to KOR in detergent micelles was lost, KOR reconsti-
tuted in Nanodiscs maintained ligand binding with 73.5 ± 2.5% (n = 5) relative to the initial
activity.
As for KOR in DDMmicelles, the time-dependent traces of ligand-binding activity were fit-
ted to an exponential decay function to quantify the half-life of receptor activity. However, two
exponentials were necessary to fit the data of KOR reconstituted in Nanodiscs properly, which
Fig 2. Reconstitution of KOR in Nanodiscs. A) SEC chromatogram (Superdex200) representing UV280 nm traces from resolution of empty Nanodiscs
(black dotted line) and of KOR/Nanodisc complexes (black line). KOR/Nanodisc sample eluted as two peaks. The second peak on the chromatogram
corresponded to Nanodiscs containing active KOR, confirmed by specific binding of [3H]-DPN (10 nM) to KOR in eluted fractions (red circles). The column
was calibrated with standard proteins indicated by arrows. The Stokes diameters of empty Nanodiscs and KOR/Nanodisc complexes were calculated to be
11.9 nm and 14.1 nm respectively. B) SDS-PAGE detection of KOR reconstituted in Nanodiscs. Left: Coomassie brilliant blue staining, KOR (66 kDa) was
visible around 75 kDa while the MSP1E3D1 protein (32.6 kDa) was visible at 30 kDa. Right: The presence of KOR was confirmed by western blot
detection with streptavidin alkaline phosphatase binding to the C-terminal biotin-tag of KOR. Original uncropped and unadjusted gel and blot can be seen in
S2 Fig.
doi:10.1371/journal.pone.0150658.g002
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suggested that at least two populations of receptors were present in the sample. As indicated by
the SEC profile (Fig 2), a part of the receptor/Nanodisc complexes were aggregated and present
in the Superdex200 void volume. However, this fraction may correspond to the component of
receptor with reduced stability.
Analyzed from the fitted curve, the stability was improved approximately 70 fold when the
average half-life (Taverage, 17.8 ± 1.1 hours) of ligand binding activity to KOR reconstituted in
Nanodiscs was compared to the half-life (0.25 ± 0.01 hours) obtained for KOR in DDM
micelles (Fig 3 and Table 1). For the major part of the receptor population reconstituted in
Nanodiscs (68.9%) the half-life of the slow component of ligand binding decay was 25.5 ± 1.1
hours. The improved stability of the majority of reconstituted KOR facilitated the use of the
receptor for further characterization.
Pharmacological properties of KOR/Nanodisc complexes
To confirm that the receptor function was preserved during isolation and reconstitution into
Nanodiscs, the pharmacology of KOR was characterized by applying SPA as a classical activity
assay (Fig 4).
Fig 3. Time-resolved stability of KOR in detergent or when reconstituted in Nanodiscs. Stability of high-
affinity ligand binding (10 nM [3H]-DPN 10 x KD) to KOR in 0.1%/0.02% DDM/CHS (w/v) micelles (open
diamonds) or to KOR reconstituted in Nanodiscs (black diamonds) at 23°C. Specific [3H]-DPN binding was
normalized to initial ligand binding at time zero where incubation at RT was initiated. Data are average of at
least three experiments each performed in triplicates. Error bars represents standard error of the mean. Data
were fitted to a double exponential decay curve to calculate the half-life of high-affinity ligand binding to KOR
(see Table 1).
doi:10.1371/journal.pone.0150658.g003
Table 1. Quantification of high-affinity ligand binding to KOR in detergent micelles or when reconstituted in Nanodiscs.
N1 (%) τ1 (hours) t1 (hours) N2 (%) τ2 (hours) t2 (hours) Taverage (hours)
KOR in DDM micelles* 97.4 ± 1.5 0.4 ± 0.01 0.3 ± 0.01 - - - -
KOR in Nanodiscs 29.4 ± 0.8 1.2 ± 0.1 0.8 ± 0.1 68.9 ± 0.7 36.8 ± 1.6 25.5 ± 1.1 17.8 ± 1.1
Data presented in Fig 3, were ﬁtted to either a single- (*) or a double exponential decay function. Half-life (t) was calculated from the exponential time
constant (τ). N denotes the initial active receptor population (t = 0) calculated from the ﬁt. The average half-life (Taverage) was calculated from N1, N2, t1 and
t2. Errors represent standard deviation from the ﬁt.
doi:10.1371/journal.pone.0150658.t001
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The affinity constant (KD) of [
3H]-DPN binding to KOR/Nanodisc complexes was calcu-
lated to 0.84 ± 0.15 nM, comparable to the affinity of membrane bound receptors calculated to
0.94 ± 0.14 nM (Fig 4A, Table 2) and in agreement with literature values [32,51] (Table 2). To
further investigate the pharmacology of KOR in P. pastoris cell membrane and when reconsti-
tuted in Nanodiscs, the antagonist naloxone and the peptide agonist dynorphin A (1–17) were
tested in competition binding experiments using SPA. Calculated IC50 values were converted
into inhibition constants (Ki) and are listed in Table 2. Inhibition of [
3H]-DPN with unlabeled
naloxone showed similar pharmaceutical behavior of KOR in Nanodiscs and in membranes
(Table 2 and Fig 4B). In contrast, a significant shift in Ki was measured for dynorphin A (1–
17), indicating a higher affinity for the peptide to the receptor when reconstituted in Nanodiscs
compared to KOR in P. pastorismembrane (Table 2 and Fig 4C). Additionally, the measured
affinity of dynorphin A (1–17) for KOR in Nanodiscs is in accordance with literature values
and indicates that the lipid composition can be important for high affinity binding of dynor-
phin A (1–17) to KOR.
KOR activation is furthermore defined by agonist-induced binding of the Gα-subunit of the
heterotrimeric G proteins of the Gi/o family. In addition, some studies indicate that KOR can
Fig 4. Pharmacology of KOR in isolated P. pastorismembrane and when reconstituted in Nanodiscs. A) Saturation binding assay of [3H]-DPN binding
to KOR in membrane (black triangles) or KOR reconstituted in Nanodiscs (open triangles). From the specific binding the affinity constant, KD, of [
3H]-DPN
binding to KOR was calculated by fitting to a one-site binding model (see Table 2) B) Competition binding experiments with KOR antagonist naloxone and C)
KOR agonist dynorphin A (1–17). Increasing concentrations of ligand competed the binding of 0.8 nM [3H]-DPN binding to KOR in P. pastoris cell membrane
(black marks) or reconstituted in Nanodiscs (open marks). The calculated binding constants (Ki) are shown in Table 2. Data shown are representative
experiments of specific binding normalized to initial binding of [3H]-DPN binding to KOR. Data points are shown with standard deviation of triplicate
measurements in one assay. All binding experiments were repeated at least three times.
doi:10.1371/journal.pone.0150658.g004
Table 2. Comparison of binding affinities (KD, Ki) of KOR in P. pastorismembranes or in Nanodiscs.
P.Pastoris membrane KOR/Nanodiscs Literature
[3H]-DPN, KD 0.9 ± 0.1 0.8 ± 0.2 0.8
Naloxone, Ki 36.3 ± 12.8 16.7 ± 2.9 9.6
Dynorphin A (1–17), Ki 104.8 ± 57.2 6.1 ± 2.1 0.4–14.9
Calculated afﬁnity constants (KD, nM) and displacement constants (Ki, nM) of ligand binding to KOR in P. pastoris membranes or to KOR/Nanodisc
complexes. Literature values are from [31,52].
doi:10.1371/journal.pone.0150658.t002
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also couple to Gq/11 proteins and activate the phospholipase C pathway [53]. To confirm that
the isolated and reconstituted KOR was able to activate G-proteins, we used the non-hydroly-
sable fluorescently labeled BODIPY FL GTPγS to measure receptor-catalyzed GTPγS binding
to purified Gαi in the presence of Gβγ (Fig 5). Due to a change in the chemical environment
near the fluorophore, the fluorescence of BODIPY FL GTPγS increases when it binds to the Gα
subunit [35]. When KOR was stimulated by dynorphin A (1–17), a substantial increase in the
fluorescence signal from BODIPY FL GTPγS was detected, when compared to both the signal
from the assay performed in the absence of ligand and from the assay done with empty Nano-
discs (Fig 5). Compared to KOR/Nanodisc samples in the absence of agonist, the fluorescence
of agonist stimulated KOR/Nanodisc sample increased by 56% (Fig 5). This preliminary data
suggest that KOR reconstituted in Nanodiscs can activate Gi proteins in vitro.
The binding of different ligands to KOR and receptor-stimulated G-protein activation, sug-
gest that KOR was successfully reconstituted in Nanodiscs and maintained a pharmacology
that was comparable or even improved compared to KOR in P. pastorismembrane.
Discussion
Amajor bottleneck, for MP investigation and the use of isolated MPs in early stage of drug dis-
covery, is that MPs need to be extracted from the membrane using detergents, which often
destabilize their biological function. Furthermore, MPs remain in detergent solution through
often extensive purification protocols and during subsequent experiments. This is for instance
the case when purified MPs are immobilized on a biosensor surface for screening of fragment
libraries and for measuring the kinetics of ligand binding, which can last for several hours
[19,54,55]. Consequently long-term functional stability of MPs in solution is a key require-
ment, in order to conduct investigations at the molecular level.
The stability of MPs in detergent solution can be measured by several different analytical
techniques. The most common method is to measure the thermostability of proteins by circular
dichroism spectroscopy, differential scanning calorimetry or binding of fluorescent dyes to
exposed hydrophobic residues. These techniques are limited, both because they require puri-
fied sample and often relatively large quantities. Many MPs, especially GPCRs, are not
Fig 5. Isolated KOR reconstituted in Nanodiscs activated Gi protein. BODIPY FL GTPγS was used to
confirm Gαi protein activation by KOR after isolation and reconstitution into Nanodiscs. The intrinsic activity of
G proteins was measured in the presence of empty Nanodiscs (light grey, Empty ND). Compared to KOR/
Nanodisc sample without agonist stimulation (KOR/ND, dark grey), the fluorescence from BODIPY FL
GTPγS binding to Gαi increased by 56% when the KOR/Nanodisc sample was stimulated with 1 μM
dynorphin A (1–17) (KOR/ND + Dyn A, dark grey). Error bars represent standard error of the mean between
two independent experiments.
doi:10.1371/journal.pone.0150658.g005
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sufficiently stable in detergent solution to be purified to a reasonable level and in sufficient
quantities. Furthermore, the methods do not determine if receptors retain their native pharma-
cology [37,56]. Here, we used time-resolved SPA as an assay to quantify high-affinity ligand
binding to a pharmaceutical relevant GPCR in detergent micelles, and to validate long-term
stabilization of Nanodisc-reconstituted receptors. Compared to the above-mentioned tech-
niques, the stability could be assayed directly after membrane solubilization without prior puri-
fication, since the receptor was immobilized on SPA beads from crude detergent extracted
membrane fragments. Moreover, thermal stability assays would be inappropriate to assess
Nanodisc reconstituted receptor stability, since they rely on thermal denaturation curves,
where the whole lipoprotein complex would interfere with the measurements.
Compared to conventional radioligand binding assays that rely on separation techniques,
such as filter binding assays, SPA binding assay avoid usual filtration and washing procedures.
Standard filtration assays can be challenging for dissolved MPs or nanoparticles in general,
because of the relatively large filter pore size and thus loss of sample. Furthermore, the obtained
information about a given receptor activity is limited to single endpoints at a given time. Using
SPA as a time-resolved assay, where the same assay was counted repeatedly, the obtained data
had a high degree of information. From the time-resolved data, the receptor activity monitored
over a prolonged period of time could be fitted to an exponential decay function and the half-
life of high-affinity ligand binding could be quantified. In addition, for a complete time-
resolved depiction of receptor activity, the consumption of receptor sample (30 fmol) and
assay reagents were minimal. Since SPA is a homogeneous”mix-and-measure assay” several
conditions could be tested in parallel, and the assay could easily be automated to assess receptor
activity over time directly.
We investigated the long-term functional stability of isolated KOR, in detergent and after
reconstitution into Nanodiscs, using SPA as a time-resolved assay to measure the decay of
high-affinity ligand binding. The human KOR was overexpressed in P. pastoris and extracted
from the cell membrane by DDM, a detergent that is often successfully used for GPCRs solubi-
lization. When SPA was used to analyze the time course of [3H]-DPN binding to KOR at room
temperature, the signal decreased rapidly with a calculated half-life of 15.3 ± 0.5 minutes and
undetectable after 100 minutes. The same fast decrease in binding was measured with a differ-
ent separation technique, which confirmed that SPA is valid to assay ligand-binding stability
over time (Fig 1B).
Because of the unstable nature of KOR in DDM solution, extracted receptors were not suit-
able for further investigation, even though DDM has proven to be a suitable detergent for KOR
solubilization [31,41]. The expression system used in this study, may affect the stability of solu-
bilized receptors. Furthermore KOR used for structural studies, was genetically modified to
improve the thermal stability of the protein [31]. The functional long-term stability of KOR
reconstituted in Nanodiscs was remarkably increased, compared to receptors in detergent solu-
tion (Fig 3, Table 1). When analyzed with time-resolved SPA the half-life of the high-affinity
ligand binding to KOR, was improved from 15.3 ± 0.5 minutes to 17.8 ± 1.1 hours and the
receptor was active for up to 12 hours at room temperature. To our knowledge, only one study
investigated the biological stability of a GPCR over time when reconstituted in rHDL particles,
comparable to Nanodiscs. The time dependent binding of conformational sensitive antibodies
to a GPCR was followed by immobilization on a SPR sensor chip. In DDMmicelles, the bind-
ing of antibodies decreased by 93% within 24 hours at 4°C, whereas only 15% antibody binding
was lost when the receptor was reconstituted in rHDL [10]. The functional stability of KOR
reconstituted in Nanodiscs is comparable and thus meets the requirements of long-term stabil-
ity to perform measurements with e.g. SPR.
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After reconstitution of KOR in Nanodiscs, the pharmacology of KOR was preserved and
comparable to KOR embedded in P. pastorismembrane or even improved in the case of the
peptide agonist dynorphin A (1–17) (Fig 4). Compared to KOR in P. pastorismembrane
patches, the affinity of dynorphin A (Ki) was enriched 20-fold when receptors were reconsti-
tuted in Nanodiscs. The increased affinity indicates that the lipid composition can be of impor-
tance for the interaction between KOR and the peptide agonist dynorphin A (1–17) [57,58].
In addition, G protein activation by KOR was confirmed by increased binding level of BOD-
IPY FL GTPγS to Gαi when KOR was stimulated by dynorphin A (1–17) (Fig 4). This is the
first time G protein activation is demonstrated for KOR in vitro. Such assay format is impor-
tant to demonstrate the actual activity of a GPCR and to characterize the intrinsic nature of
ligands acting as agonists, antagonists or inverse agonists. Furthermore, isolated KOR can be
used to investigate the molecular interactions controlling activation of different G protein sub-
type pathways or for investigation of biased agonism, where ligands selectively induce either G
protein or β-arrestin-dependent signaling pathways. For these in vitro investigations a func-
tional receptor stable for longer periods is crucial.
Conclusion
Long-term stability of intrinsic unstable MPs is the key to obtain high quality data to under-
stand MPs molecular mechanisms and to develop new highly selective drug-candidates. We
have shown that time-resolved SPA has the potential to efficiently screen and identify condi-
tions that can improve functional stability of a highly fragile GPCR. SPA counted repeatedly
was used as a straightforward "mix-and-read" assay, to access information on long-term stabil-
ity of high-affinity ligand binding to KOR. Using this approach, we showed how the functional
long-term stability of KOR was highly improved from being in detergent solution and after a
successful reconstitution into Nanodiscs. The functional stability of receptors was necessary to
characterize the pharmacology of KOR reconstituted in Nanodiscs.
SPA is already a common technique, used in both academia and in the pharmaceutical
industry. The variety of beads and immobilization strategies available, such as beads functiona-
lized with nickel chelate to immobilize proteins with a histidine affinity tag, makes the pre-
sented method relevant for a wide range of MPs. Time-resolved SPA can be used to optimize
the conditions for long-term stability of MPs, that is required for many techniques used to
understand MPs at the molecular level and to develop new drug candidates from compound
screenings with isolated proteins as targets.
Supporting Information
S1 Fig. Stability of high-affinity ligand binding to KOR solubilized in various detergents
measured by time-resolved SPA. Several detergents was tested, here an example of 1%/0.2%
DDM compared to 0.5%/0.1% CHAPS is shown. P. Pastorismembranes were solubilized in
either 0.5%/0.1% CHAPS/CHS (red) or 1%/0.2% DDM/CHS (blue). To measure specific bind-
ing of radioligand to KOR, solubilized proteins were mixed with streptavidin SPA beads and
[3H]-DPN at saturating concentration for high-affinity ligand binding (10 nM [3H]-DPN
10xKD). Non-specific binding was measured in parallel by including 50 μM naloxone. The final
concentration of detergents after sample dilution in the assay was; 0.1%/0.02% for DDM/CHS
and 0.5/0.2% for CHAPS/CHS. The assay was repeatedly counted at room temperature. Spe-
cific [3H]-DPN binding to KOR was normalized to initial activity of each sample. The observed
decay of radioligand binding to KOR could be fitted to a first-order exponential decay function
(dashed lines). The half-life of high-affinity ligand binding to KOR in DDMmicelles was
15.3 ± 0.5 minutes and for KOR in CHAPS micelles the half-life was measured to 69.3 ± 2.8
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minutes. The quantity of total solubilized protein in CHAPS detergent (10.3 ± 0.3%) was lower
than for DDM solubilization (57.1% ± 3.6%). Therefore the later was used for further purifica-
tion even though the stability of ligand binding was lower. All data points are average of three
independent experiments each performed in triplicates. Error bars represent the standard error
of the mean.
(DOCX)
S2 Fig. SDS-PAGE detection of KOR, uncropped and unadjusted gel lanes. A) Coomassie
brilliant blue staining. B) Western blot detection with streptavidin alkaline phosphatase bind-
ing to the C-terminal biotin-tag of KOR.
(DOCX)
S1 Table. Identification of KOR by MALDI mass spectrometry. Sequence coverage was 7%
and the protein was identified as kappa-type opioid receptor isoform 2 (Homo sapiens), which
suggest that the identified protein was KOR.
(DOCX)
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